COEPCoeptis Therapeutics, Inc.

COEP Stock Price, Valuation & Chart | Coeptis Therapeutics, Inc.

Compare

$10.990-1.03 (-8.57%)

At close · 02 July 2026, 07:59 pm

Sector: Healthcare Industry: Biotechnology COEP intrinsic value COEP calculated fair value vs price

Overview Financials Dividends Ratios

COEP Historical price chart

COEP Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization38.62M

PE Ratio-3.91

EPS-2.81

Trading Volume408.20K

Today's High/Low11.99/10.81

Dividend Yield0.00

52 Week High/Low21.41/6.8

Shares Outstanding3.51M

COEP Financial Statement

COEP Analyst ratings

COEP Analysis & performance metrics

COEP Company profile

Coeptis Therapeutics, Inc., a biopharmaceutical company, develops and commercializes generic and branded pharmaceutical products and cell therapy platforms for patients with…

Coeptis Therapeutics, Inc., a biopharmaceutical company, develops and commercializes generic and branded pharmaceutical products and cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a Vy-Gen drug product for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; and…

COEP Management team

Name

Position

David MehalickCEO

Co-Founder, Chairman of the Board, Chief Executive Officer & President

Daniel Alexander YeraceCTO

Co-Founder, Vice President of Operations & Director

Colleen Delaney M.D., M.Sc.

Consultant

Christine Elise Sheehy

Co-Founder and Vice President of Compliance & Corporate Secretary

Brian Cogley M.B.A.CFO

Chief Financial Officer

Name

Position

David MehalickCEO

Co-Founder, Chairman of the Board, Chief Executive Officer & President

Daniel Alexander YeraceCTO

Co-Founder, Vice President of Operations & Director

Colleen Delaney M.D., M.Sc.

Consultant

Christine Elise Sheehy

Co-Founder and Vice President of Compliance & Corporate Secretary

Brian Cogley M.B.A.CFO

Chief Financial Officer

Management Team

David MehalickCEO

Co-Founder, Chairman of the Board, Chief Executive Officer & President

Daniel Alexander YeraceCTO

Co-Founder, Vice President of Operations & Director

Colleen Delaney M.D., M.Sc.

Consultant

Christine Elise Sheehy

Co-Founder and Vice President of Compliance & Corporate Secretary

Brian Cogley M.B.A.CFO

Chief Financial Officer

Management

David MehalickCEO

Co-Founder, Chairman of the Board, Chief Executive Officer & President

Daniel Alexander YeraceCTO

Co-Founder, Vice President of Operations & Director

Colleen Delaney M.D., M.Sc.

Consultant

Christine Elise Sheehy

Co-Founder and Vice President of Compliance & Corporate Secretary

Brian Cogley M.B.A.CFO

Chief Financial Officer

Total 5 executives

COEP Frequently asked questions

What is Coeptis Therapeutics, Inc. (COEP) Stock Price?

Current stock price of Coeptis Therapeutics, Inc. (COEP) stock is $10.990. The stock price is -8.57% lower in the session. The intraday range can be seen from this page. Volume of Coeptis Therapeutics, Inc. (COEP) stock is 408.20K.

Last updated at 02 July 2026, 07:59 pm.

Why is the Coeptis Therapeutics, Inc. (COEP) stock price going up or down today?

The stock price of Coeptis Therapeutics, Inc. (COEP) can change with earnings, company news, and overall market sentiment. Coeptis Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Coeptis Therapeutics, Inc. stock expensive at its current price?

Whether Coeptis Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for COEP on this page is -3.91. EPS on this page is -2.81. Compare those figures with peers and growth expectations before deciding if the current Coeptis Therapeutics, Inc. price is justified.

How has the stock price of Coeptis Therapeutics, Inc. (COEP) performed historically?

Historical performance for Coeptis Therapeutics, Inc. (COEP) is shown on the price chart on this page. Review multi-period moves alongside volume to see how COEP reacted to past earnings and market events.

Should I buy Coeptis Therapeutics, Inc. (COEP) stock, at this price?

Buying Coeptis Therapeutics, Inc. (COEP) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.